A randomized, double-blind, placebo-controlled, parallel-group, multicenter Phase 3 study to investigate the efficacy and safety of finerenone, in addition to standard of care, on the progression of kidney disease in subjects with non-diabetic chronic ...
Lay Description
Category
- Urinary Tract and Kidney
- IRB Number
- 20210618HU
- NCT Number
- ct.gov registration not required
- Open to Enrollment
- Yes
Eligibility
- Eligible Ages
- Eligible Genders
- Accepts Healthy Volunteers
Inclusion Criteria
Exclusion Criteria
Study Design
Arm Groups
Study Contact
Shweta Bansal
2100-567-5338
bansals3@uthscsa.edu
Aliseiya Garza
(210) 567-4700
garzaa35@uthscsa.edu
Myriam Gonzalez
(210) 562-6516
gonzalezm38@uthscsa.edu
Principal Investigator
Shweta Bansal